Standout Papers

Cardiolipin, Mitochondria... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Cardiolipin, Mitochondria, and Neurological Disease
    2021 168 citations Micol Falabella, Hilary J. Vernon et al. Trends in Endocrinology and Metabolism profile →

Immediate Impact

6 from Science/Nature 55 hit
Sub-graph 1 of 24

Citing Papers

Luminescent Lanthanides in Biorelated Applications: From Molecules to Nanoparticles and Diagnostic Probes to Therapeutics
2025 Hit
Mitochondrial diseases: from molecular mechanisms to therapeutic advances
2025 Hit
1 intermediate paper

Works of Micol Falabella being referenced

Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges
2022
Functional Characterization of Peroxiredoxins from the Human Protozoan Parasite Giardia intestinalis
2014

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Micol Falabella 439 82 79 53 51 18 658
Martin H. Wisher 384 0.9× 73 0.9× 29 0.4× 93 1.8× 23 0.5× 18 755
Elżbieta Wałajtys-Rode 357 0.8× 219 2.7× 215 2.7× 37 0.7× 21 0.4× 37 751
Elizabeth C. Hinchy 363 0.8× 97 1.2× 34 0.4× 25 0.5× 27 0.5× 11 597
Ouma Onguka 523 1.2× 68 0.8× 100 1.3× 11 0.2× 22 0.4× 14 760
Wendy Trzyna 277 0.6× 91 1.1× 21 0.3× 40 0.8× 30 0.6× 16 698
Stephen J. Fairweather 302 0.7× 74 0.9× 68 0.9× 79 1.5× 9 0.2× 18 616
Robert L. Dryer 283 0.6× 140 1.7× 37 0.5× 10 0.2× 31 0.6× 29 762
Milinda E. James 223 0.5× 207 2.5× 29 0.4× 18 0.3× 17 0.3× 17 752
Daniela Cosentino‐Gomes 347 0.8× 170 2.1× 23 0.3× 30 0.6× 31 0.6× 23 794
Anuradha Tarafdar 278 0.6× 106 1.3× 32 0.4× 63 1.2× 36 0.7× 25 739

All Works

Loading papers...

Rankless by CCL
2026